| Rachel Michelle Eifert, DDS | |
|
8605 N Dixie Dr, Dayton, OH 45414-2403 | |
| (937) 264-1600 | |
| Not Available |
| Full Name | Rachel Michelle Eifert |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 8605 N Dixie Dr, Dayton, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063903961 | NPI | - | NPPES |
| 30.025409 | Other | OH | OHIO STATE DENTAL BOARD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 30.025409 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Michelle Eifert, DDS 8605 N Dixie Dr, Dayton, OH 45414-2403 Ph: (937) 264-1600 | Rachel Michelle Eifert, DDS 8605 N Dixie Dr, Dayton, OH 45414-2403 Ph: (937) 264-1600 |
News Archive
Negative stereotypes about boys may hinder their achievement, while assuring them that girls and boys are equally academic may help them achieve. From a very young age, children think boys are academically inferior to girls, and they believe adults think so, too. Even at these very young ages, boys' performance on an academic task is affected by messages that suggest that girls will do better than they will.
Amgen and GlaxoSmithKline (GSK) today announced a collaboration in which the companies will share commercialization of Amgen's monoclonal antibody denosumab for postmenopausal osteoporosis (PMO) in Europe, Australia, New Zealand and Mexico once the product is approved in these countries.
Regular physical activity could play a role in helping women at high-risk of breast cancer delay the need for drastic preventive measures such as prophylactic mastectomy, according to new research led by the Perelman School of Medicine at the University of Pennsylvania.
Onconova Therapeutics, Inc., announced today the advancement of the oral formulation of rigosertib, an anti-cancer agent with demonstrated activity in solid tumors and hematologic malignancies, into a new Phase II study. The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the U.S. and EU.
Biota Holdings Limited and MedImmune Inc. today announced the start of a Phase Ia clinical trial for their respiratory syncytial virus (RSV) antiviral drug, BTA9881, with the goal of providing a treatment for RSV-infected infants and adults.
› Verified 1 days ago
Michele Lynn Bloxson, DDS Dentist Medicare: Medicare Enrolled Practice Location: 4257 W 3rd St, Dayton, OH 45417 Phone: 937-268-1665 | |
Dr. Anthonio Collins Mcfadden, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 5221 Waynetowne Ct, Dayton, OH 45424 Phone: 937-237-0360 | |
Ihab F Messiha, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 5200 Salem Ave, Dayton, OH 45406 Phone: 937-854-7617 Fax: 937-837-1554 | |
Dr. Gary Howard Ensor, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1 Wyoming St, Department Of Medical Education, Dayton, OH 45409 Phone: 937-208-2204 Fax: 937-208-5393 | |
Dr. James A Budde Iii, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 5660 Far Hills Ave, Dayton, OH 45429 Phone: 937-435-0324 Fax: 937-435-7206 | |
Stephen M. Joseph, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 1654 S Smithville Rd, Dayton, OH 45410 Phone: 937-252-8551 Fax: 937-252-4311 | |
Dr. David Jeremiah Young, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3080 Ackerman Rd, Dayton, OH 45429 Phone: 937-298-7267 Fax: 937-298-0672 |